Category: Nouvelles | Page 10

Understanding prescribing trends for hepatitis C treatment in Ontario

24 February 2021 • Par Mary Guyton, RN, Jennifer Broad and Kate Mason

The introduction and wide availability of direct-acting antivirals (DAAs) as a treatment for hepatitis C through a phased rollout from 2015 to 2018 held the promise of expanded access to treatment. These simpler treatments carried fewer clinical restrictions and required less specialist support, opening the possibility for primary care providers to treat their patients with hepatitis C. Given barriers to healthcare access for people who use drugs, those of us at the Toronto Community Hep C Program were curious to find out if this had in fact happened.

Pour en savoir plus...

La COVID-19, les couvre-feux et la crise des surdoses : Une perspective québécoise

17 February 2021 • Par Frankie Lambert et Chantal Montmorency

Pour mieux comprendre les enjeux et les priorités des personnes qui utilisent des drogues au Québec lors de la pandémie de COVID-19 et de la crise des surdoses, CATIE a mené une courte entrevue avec Frankie Lambert et Chantal Montmorency, deux membres de l’équipe de l’Association québécoise pour la promotion de la santé des personnes utilisatrices de drogues (AQPSUD). Voici ce qui tient à cœur à leur communauté.

Pour en savoir plus...

Indigenous responses to COVID-19 and hepatitis: A conference report back

28 January 2021 • Par Dr. Alexandra King and Sarah MacDonald

Viral hepatitis impacts Indigenous peoples around the world at much higher than average rates, harming their physical, spiritual, emotional, social and economic health. This is the result of historic and ongoing colonialism, and includes significantly worse health determinants, inadequate access to immunization and treatment, and inadequacies in the provision of culturally safe and responsive healthcare to Indigenous people. COVID-19 has further impacted Indigenous peoples, but many communities and healthcare practitioners are finding innovative ways of responding to the pandemic, while simultaneously trying to continue providing hepatitis care. Many of these responses were shared in a virtual mini-conference hosted by the...

Pour en savoir plus...

Making OraQuick quicker: The VIRCAN 5-Minute Rule

20 January 2021 • Par David Smookler and Aaron Vanderhoff

Point-of-care (POC) tests for hepatitis C expand testing beyond clinical settings where a blood draw is not readily available. They are an important tool in the effort to eliminate hepatitis C as an endemic disease by 2030. The only Health Canada-approved POC test is the OraQuick hepatitis C antibody test, which requires a 20-minute wait before the results can be read.

Pour en savoir plus...

What do online users want from HIV/STI risk calculators?

11 January 2021 • Par Oralia Gómez-Ramírez and Hsiu-Ju Chang

Risk calculators for HIV and other sexually transmitted infections (STIs) use answers to a set of sociodemographic characteristics (e.g., age, sex, ethnicity, geographic location), health status, or behavioural questions to estimate a person’s risk for developing or acquiring HIV and STIs. They can also indicate the most appropriate action for users to take.

Pour en savoir plus...

Sujets vedettes de 2020 dans le Blogue de CATIE

21 December 2020 • Par Alexandra Murphy

L’année 2020 laissera une marque indélébile dans notre conscience collective : la planète est confrontée à la nouvelle maladie à coronavirus (COVID-19). Cette pandémie semble avoir consumé nos vies. Pour plusieurs d’entre nous, pas un jour ne passe sans que nous pensions au virus, à la façon dont il a modifié nos activités quotidiennes et à ce que nous devons faire pour que nos communautés demeurent en santé. Depuis que le virus a frappé le Canada en mars 2020, les prestataires de services aux quatre coins du pays se sont mobilisés pour assurer la sécurité de leurs clients et leur fournir les soins...

Pour en savoir plus...